Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

In this study in silico docking models were employed to investigate the molecular interactions between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein, derived from the ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

(A) A comprehensive analysis of caffeine binding to one of the spike proteins; (B, C) Caffeine interacts with critical amino acids in the SARS-CoV-2 S protein’s receptor-binding domain (RBD), ...

The COVID-19 pandemic drove a large volume of in vitro diagnostic test efforts toward the SARS-CoV-2 virus, such as the Biofire respiratory panel by Biofire Diagnostics LLC, of Salt Lake City, a test ...

The pharmaceutical company Moderna announced promising results from the ongoing trial of its new vaccine, mRNA-1083. When you purchase through links on our site, we may earn an affiliate commission.

Vaccination linked to lower risk for hospitalization, critical care unit admission, preterm birth during delta and omicron periods ...

Long COVID has lingered as one of the most unsettling legacies of the pandemic, a condition that can derail lives long after ...

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in infants, children, and adolescents.